Literature DB >> 2877046

Analysis of multiple restriction fragment length polymorphisms of the gene for the human complement receptor type I. Duplication of genomic sequences occurs in association with a high molecular mass receptor allotype.

W W Wong, C A Kennedy, E T Bonaccio, J G Wilson, L B Klickstein, J H Weis, D T Fearon.   

Abstract

Human CR1 exhibits an unusual form of polymorphism in which allotypic variants differ in the molecular weight of their respective polypeptide chains. To address mechanisms involved in the generation of the CR1 allotypes, DNA from individuals having the F allotype (250,000 Mr), the S allotype (290,000 Mr), and the F' allotype (210,000 Mr) was digested by restriction enzymes, and Southern blots were hybridized with CR1 cDNA and genomic probes. With the use of Bam HI and Sac I, an additional restriction fragment was observed in 20 of 21 individuals having the S allotype with no associated loss of other restriction fragments. Southern blot analysis with a noncoding genomic probe derived from the S allotype-specific Bam HI fragment showed hybridization to this fragment and to two other fragments that were also present in FF individuals. Thus, an intervening sequence may be repeated twice in the F allele and three times in the S allele. A restriction fragment length polymorphism (RFLP) unique to two individuals expressing the F' allotype was seen with Eco RV, but the absence of persons homozygous for this rare allotype prevented further comparisons with the F and S allotypes. Analysis of the CR1 transcripts associated with the three CR1 allotypes indicated that these differed by 1.3-1.5 kb and had the same rank order as the corresponding allotypes. Taken together, these findings suggest that the S allele was generated from the F allele by the acquisition of additional sequences, the coding portion of which may correspond to a long homologous repeat of approximately 1.4 kb that has been identified in CR1 cDNA. We saw two other RFLPs with Hind III and Pvu II that were in linkage dysequilibrium with the Bam HI-Sac I RFLPs associated with the S allotype, and a third polymorphism was seen with Eco RI that was not in linkage dysequilibrium with the other polymorphisms. Thus, 10 commonly occurring CR1 alleles can be defined, making this locus a useful marker for the long arm of chromosome 1 to which the CR1 gene maps.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877046      PMCID: PMC2188435          DOI: 10.1084/jem.164.5.1531

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Polymorphism of human erythrocyte C3b/C4b receptor.

Authors:  T R Dykman; J L Cole; K Iida; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

2.  Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.

Authors:  M Reynes; J P Aubert; J H Cohen; J Audouin; V Tricottet; J Diebold; M D Kazatchkine
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

3.  Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).

Authors:  T Seya; V M Holers; J P Atkinson
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

4.  Two subtypes of BfF by isoelectrofocusing: differential linkage to other HLA markers.

Authors:  M Abbal; M Thomsen; A Cambon-Thomsen; J Archambeau; M Calot; D Fathallah
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

5.  Genetic regulation of a structural polymorphism of human C3b receptor.

Authors:  W W Wong; J G Wilson; D T Fearon
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

6.  PMA induces the ligand-independent internalization of CR1 on human neutrophils.

Authors:  P S Changelian; R M Jack; L A Collins; D T Fearon
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

7.  Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.

Authors:  S H Yoon; D T Fearon
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

8.  Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele.

Authors:  T R Dykman; J A Hatch; M S Aqua; J P Atkinson
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

9.  Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus.

Authors:  T R Dykman; J A Hatch; J P Atkinson
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

10.  Human genes for three complement components that regulate the activation of C3 are tightly linked.

Authors:  S Rodriguez de Cordoba; D M Lublin; P Rubinstein; J P Atkinson
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  12 in total

1.  Soluble form of complement C3b/C4b receptor (CR1) results from a proteolytic cleavage in the C-terminal region of CR1 transmembrane domain.

Authors:  I Hamer; J P Paccaud; D Belin; C Maeder; J L Carpentier
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

Review 2.  CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.

Authors:  J G Wilson; N A Andriopoulos; D T Fearon
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 3.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

4.  The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.

Authors:  F Moldenhauer; M Botto; M J Walport
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

5.  Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.

Authors:  L B Klickstein; W W Wong; J A Smith; J H Weis; J G Wilson; D T Fearon
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

6.  Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.

Authors:  W W Wong; J M Cahill; M D Rosen; C A Kennedy; E T Bonaccio; M J Morris; J G Wilson; L B Klickstein; D T Fearon
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

7.  Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans.

Authors:  J Rey-Campos; P Rubinstein; S Rodriguez de Cordoba
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

8.  A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP.

Authors:  J Rey-Campos; P Rubinstein; S Rodriguez de Cordoba
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

9.  Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.

Authors:  L B Klickstein; T J Bartow; V Miletic; L D Rabson; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.

Authors:  D Hourcade; D R Miesner; J P Atkinson; V M Holers
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.